GB1296510A - - Google Patents
Info
- Publication number
- GB1296510A GB1296510A GB1296510DA GB1296510A GB 1296510 A GB1296510 A GB 1296510A GB 1296510D A GB1296510D A GB 1296510DA GB 1296510 A GB1296510 A GB 1296510A
- Authority
- GB
- United Kingdom
- Prior art keywords
- salts
- physiologically
- veterinarily acceptable
- mono
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- AUYYCJSJGJYCDS-UHFFFAOYSA-N 2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid Chemical compound IC1=CC(CC(N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-UHFFFAOYSA-N 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 239000004411 aluminium Substances 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- 150000001669 calcium Chemical class 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 1
- 239000003701 inert diluent Substances 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 150000002641 lithium Chemical class 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 125000005270 trialkylamine group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712126533 DE2126533A1 (de) | 1971-05-28 | 1971-05-28 | Verfahren zur Herstellung pharma zeutischer Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1296510A true GB1296510A (de) | 1972-11-15 |
Family
ID=5809169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1296510D Expired GB1296510A (de) | 1971-05-28 | 1971-09-17 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3917832A (de) |
| AT (1) | AT306228B (de) |
| AU (1) | AU3450471A (de) |
| BE (1) | BE773121A (de) |
| BR (1) | BR7105898D0 (de) |
| DE (1) | DE2126533A1 (de) |
| ES (1) | ES394319A1 (de) |
| FR (1) | FR2139787B1 (de) |
| GB (1) | GB1296510A (de) |
| HU (1) | HU162454B (de) |
| IL (1) | IL37640A (de) |
| NL (1) | NL7111198A (de) |
| ZA (1) | ZA715734B (de) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995020954A1 (en) * | 1994-02-01 | 1995-08-10 | Knoll Ag | Tablets containing thyroid hormones |
| US5753254A (en) * | 1994-02-01 | 1998-05-19 | Knoll Aktiengesellschaft | Therapeutic agents containing thyroid hormones |
| US6458842B1 (en) | 1994-02-01 | 2002-10-01 | Knoll Aktiengesellschaft | Liquid pharmaceutical compositions comprising thyroid hormones |
| US6646007B1 (en) * | 1998-05-15 | 2003-11-11 | Merck Patent Gmbh | Process for preparing a pharmaceutical formulation containing levothyroxine sodium |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040152783A1 (en) * | 2002-11-05 | 2004-08-05 | Olon Lawrence Peter | Controlled absorption of admixed thyroid hormone formulations |
| CA2681181A1 (en) * | 2007-04-23 | 2008-10-30 | Diurnal Limited | Sustained release |
| US9968574B2 (en) * | 2009-05-15 | 2018-05-15 | The University Of Kentucky Research Foundation | Treatment of MCI and Alzheimer's disease |
| US20100292281A1 (en) * | 2009-05-15 | 2010-11-18 | The University Of Kentucky Research Foundation | Treatment of mci and alzheimer's disease |
| WO2011142778A1 (en) * | 2010-05-13 | 2011-11-17 | The University Of Kentucky Research Foundation | Treatment of mci and alzheimer's disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2925364A (en) * | 1957-08-12 | 1960-02-16 | Baxter Laboratories Inc | Method of treating hypercholesterol-emia with d-thyroxine |
| US3157574A (en) * | 1959-05-01 | 1964-11-17 | Smith Kline French Lab | Method of reducing cholesterol levels |
-
1971
- 1971-05-28 DE DE19712126533 patent/DE2126533A1/de active Pending
- 1971-08-02 AT AT674171A patent/AT306228B/de not_active IP Right Cessation
- 1971-08-13 NL NL7111198A patent/NL7111198A/xx unknown
- 1971-08-18 ES ES394319A patent/ES394319A1/es not_active Expired
- 1971-08-27 ZA ZA715734A patent/ZA715734B/xx unknown
- 1971-09-02 IL IL37640A patent/IL37640A/en unknown
- 1971-09-08 BR BR5898/71A patent/BR7105898D0/pt unknown
- 1971-09-14 HU HUME1420A patent/HU162454B/hu unknown
- 1971-09-17 GB GB1296510D patent/GB1296510A/en not_active Expired
- 1971-09-21 FR FR7133894A patent/FR2139787B1/fr not_active Expired
- 1971-09-24 US US183663A patent/US3917832A/en not_active Expired - Lifetime
- 1971-09-27 BE BE773121A patent/BE773121A/xx unknown
- 1971-10-13 AU AU34504/71A patent/AU3450471A/en not_active Expired
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995020954A1 (en) * | 1994-02-01 | 1995-08-10 | Knoll Ag | Tablets containing thyroid hormones |
| US5753254A (en) * | 1994-02-01 | 1998-05-19 | Knoll Aktiengesellschaft | Therapeutic agents containing thyroid hormones |
| US6458842B1 (en) | 1994-02-01 | 2002-10-01 | Knoll Aktiengesellschaft | Liquid pharmaceutical compositions comprising thyroid hormones |
| US6706255B2 (en) | 1994-02-01 | 2004-03-16 | Abbott Gmbh & Co., Kg | Liquid pharmaceutical compositions comprising thyroid hormones |
| US6646007B1 (en) * | 1998-05-15 | 2003-11-11 | Merck Patent Gmbh | Process for preparing a pharmaceutical formulation containing levothyroxine sodium |
| US8008349B2 (en) | 1998-05-15 | 2011-08-30 | Merck Patent Gmbh | Stable pharmaceutical preparation comprising levothyroxine sodium, gelatin and fillers and which is free of organic solvent residues |
Also Published As
| Publication number | Publication date |
|---|---|
| BR7105898D0 (pt) | 1973-05-10 |
| FR2139787A1 (de) | 1973-01-12 |
| BE773121A (fr) | 1972-03-27 |
| FR2139787B1 (de) | 1974-09-06 |
| US3917832A (en) | 1975-11-04 |
| DE2126533A1 (de) | 1972-12-14 |
| IL37640A (en) | 1974-10-22 |
| AT306228B (de) | 1973-03-26 |
| ES394319A1 (es) | 1975-04-01 |
| NL7111198A (de) | 1972-11-30 |
| AU3450471A (en) | 1973-04-19 |
| IL37640A0 (en) | 1971-12-29 |
| ZA715734B (en) | 1973-04-25 |
| HU162454B (de) | 1973-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE33269B1 (en) | Pyridobenzo-diazepine derivatives | |
| GB1320076A (en) | Therapeutic compositions containing 3-4-biphenylcarbonyl propionic acid | |
| GB1296510A (de) | ||
| GB1388358A (en) | Taste-improving formulations of oral penicillins | |
| GB1442159A (en) | Pharmaceutical compositions containing paracetamol | |
| GB1256723A (de) | ||
| GB1187946A (en) | Dimethylbiguanide Derivative | |
| GB1203328A (en) | Pharmaceutical compositions | |
| GB1237352A (en) | Substituted propylamines | |
| GB1210968A (en) | Improvements in or relating to the treatment of gastric ailments | |
| ES266474A1 (es) | Un procedimiento para preparar un complejo metalico acuosoluble | |
| GB1378413A (en) | Anti-coccidiosis composition | |
| GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
| GB1246727A (en) | Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids | |
| GB1424611A (en) | Pharmaceutical compositions | |
| GB1408542A (en) | Anthelmintic | |
| GB1098417A (en) | Pharmaceutical compositions having hypotensive activity | |
| GB1280244A (en) | Serum triglyceride-lowering compositions | |
| GB1375806A (de) | ||
| DE3260619D1 (en) | An efficiency-improving agent for feed and a preventive and treating agent for coccidiosis | |
| GB1287433A (en) | Pharmaceutical compositions | |
| GB1201736A (en) | Novel therapeutic composition | |
| GB1140655A (en) | Pyrazine derivatives | |
| IE36030L (en) | Anti-inflammatory preparations | |
| GB1266430A (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |